期刊文献+

肿瘤坏死因子相关凋亡诱导配体在多种疾病中的生物学作用 被引量:2

Biological roles of tumor necrosis factor related apoptosis-inducing ligand in clinical diseases
原文传递
导出
摘要 肿瘤坏死因子相关凋亡诱导配体(Apo2L/TRAIL)是肿瘤坏死因子家族的一员,可以诱导表达特异性死亡受体TRAIL-R1 (DR4)或TRAIL-R2 (DR5)的细胞凋亡.TRAIL可诱导多种肿瘤细胞凋亡,对正常细胞无杀伤性,因此将其作为抗肿瘤靶向治疗候选药物之一,备受关注.近期研究发现,TRAIL既通过其受体介导细胞凋亡信号通路,又可传导非凋亡的信号通路,在自身免疫病和感染性疾病中发挥重要生物学作用.因而简单阐明TRAIL在人类多种疾病中生物学作用的研究进展,对今后TRAIL研究方向和治疗策略的选择具有指导意义. Tumor necrosis factor related apotosis inducing ligand (APo2L/TRAIL) is a member of tumor necrosis factor(TNF) family,inducing apoptosis of cells expressing specific death receptor DR4 (TRAIL-R1) orDR5 (TRAIL-R2).TRAILs have been proved to induce a wide variety of tumor cell apoptosis,without damage to normal cells,which has attracted attention as one of the targeted anti-tumor drugtherapies Recently,TRAILs have been found not only inducing apoptosis,but also inducing non-apoptosis pathway upon binding to their receptors,They play important roles in autoimmune diseases and infectious diseases.In this review,we summarized the biological roles of TRAIL in a variety of human diseases,to provide references for future research directions and therapeutic strategies of TRAILs.
出处 《国际免疫学杂志》 CAS 2014年第4期268-271,共4页 International Journal of Immunology
基金 国家自然科学基金(81171973) 高校博士学科点专项科研基金(20112307110002) 黑龙江省青年科学基金(QC2011C039)
关键词 肿瘤坏死因子相关凋亡诱导配体 肿瘤 自身免疫病 感染性疾病 生物学作用 Tumor necrosis factor related apoptosis-inducing ligand Tumor Autoimmune disease Infectious disease Biological role
  • 相关文献

参考文献28

  • 1Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995,3(6):673-682.
  • 2Christina F,Uta S,Henning W.Following TRAIL' s path in the immune system[J].Immunology,2009,127 (8):145-154.
  • 3Pan G,O'Rourke K,Chinnaiyan AM,et al.The receptor for the cytotoxic ligand TRAIL[J].Science,1997,276 (5309):111-113.
  • 4Falschehner C,Emmerich CH,Gerlach B,et al.TRAIL signalling:decisions between life and death[J].Int J Biochem Cell Biol,2007,39 (7-8):1462-1475.
  • 5Varfolomeev E,Maecker H,Sharp D,et al.Molecular determinants of kinase pathway actication by APo2 ligand tumor necrosis factorrelated apoptosis-inducing ligand[J].J Biol Chem,2005,280(49):40599-40608.
  • 6Secchiero P,Zauli G.TNF-related apoptnsis-inducing ligand and the regulation of hematopoiesis[J].Curr Op Hematol,2008,15(1):42-48.
  • 7Ehrlich S,Infante-Duarte C,Seeger B,et al.Regulation of soluble and surfacebound TRAIL in human T cells,B cells,and monocytes[J].Cytokine,2003,24(6):244-253.
  • 8Bosque A,Pardo J,Martinez-Lorenzo MJ,et al.Human CD8 + T Cell blasts are more sensitive than CD4+ T Cell blasts to regulation by APO2L/TRAIL[J].Eur J Immunol,2005,35(6):1812-1821.
  • 9Bosque A,Pardo J,Maainez-Lorenzo MJ,et al.Down-regulation Of normal human T Cell blast activation:roles of APO2L/TRAIL,FasL,And c-FLIP,Bim,Or Bcl-x Isoform expression[J].J Leukoc Biol,2005,77(4):568-578.
  • 10Diao Z,Shi J,Zhu J,et al.TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CI4 + CD25 + Treg apoptosis[J].Cancer Immunol Immunother,2013,62(4):653-663.

同被引文献31

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部